Suppr超能文献

钙调蛋白抑制A10平滑肌细胞中蛋白激酶C催化的一种内源性蛋白质的磷酸化。

Calmodulin inhibits the protein kinase C-catalysed phosphorylation of an endogenous protein in A10 smooth-muscle cells.

作者信息

Zhao D Y, Hollenberg M D, Severson D L

机构信息

Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Alberta, Canada.

出版信息

Biochem J. 1991 Jul 15;277 ( Pt 2)(Pt 2):445-50. doi: 10.1042/bj2770445.

Abstract

The protein kinase C (PKC) activator phorbol 12,13-dibutyrate stimulated the phosphorylation of a 75 kDa protein (p75) in intact cultured A10 smooth-muscle cells and sonicated cell preparations; p75 was the only major substrate for endogenous PKC in sonicated A10 cells. The Ca(2+)-dependent phosphorylation of p75 in vitro was dramatically decreased in PKC-down-regulated A10 cells; however, p75 from identical sonicated cell preparations was still phosphorylated by an exogenous aortic PKC preparation. Calmodulin inhibited the phosphorylation of p75 by PKC, but not the phosphorylation of other PKC substrates (platelet P47 protein and histone). The addition of calmodulin after the phosphorylation reaction was started prevented further phosphorylation, but did not decrease the extent of phosphorylation of p75 that was reached before the addition of calmodulin. The inhibition of p75 phosphorylation was concentration-dependent, with IC50 values (concn. giving 50% inhibition) ranging from less than 0.5 to 10 micrograms of calmodulin/ml, and was Ca(2+)-dependent, requiring a free Ca2+ concentration of 10 microM or greater. These results suggest that the inhibition of the PKC-catalysed phosphorylation of p75 by calmodulin may be due to its interaction with the substrate, rather than a direct inhibitory effect on the enzyme, and that this inhibition could be regulated by intracellular Ca2+ concentration. Therefore, p75 may be a physiological link between the PKC and Ca2+/calmodulin pathways.

摘要

蛋白激酶C(PKC)激活剂佛波醇12,13 - 二丁酸酯可刺激完整培养的A10平滑肌细胞及超声破碎的细胞制剂中一种75 kDa蛋白(p75)的磷酸化;p75是超声破碎的A10细胞内源性PKC的唯一主要底物。在PKC下调的A10细胞中,p75在体外的Ca(2+)依赖性磷酸化显著降低;然而,来自相同超声破碎细胞制剂的p75仍可被外源性主动脉PKC制剂磷酸化。钙调蛋白抑制PKC对p75的磷酸化,但不抑制其他PKC底物(血小板P47蛋白和组蛋白)的磷酸化。在磷酸化反应开始后添加钙调蛋白可阻止进一步磷酸化,但不会降低添加钙调蛋白之前达到的p75磷酸化程度。p75磷酸化的抑制呈浓度依赖性,IC50值(产生50%抑制的浓度)范围为每毫升钙调蛋白小于0.5至10微克,且依赖于Ca(2+),需要10 microM或更高的游离Ca2+浓度。这些结果表明,钙调蛋白对PKC催化的p75磷酸化的抑制可能是由于其与底物的相互作用,而非对酶的直接抑制作用,并且这种抑制可能受细胞内Ca2+浓度调节。因此,p75可能是PKC与Ca2+/钙调蛋白途径之间的生理联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62fb/1151254/27c35530d1c4/biochemj00155-0145-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验